| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 150,242 | 184,372 | 445,225 | 363,315 | | Cost of Revenue | 70,433 | 87,463 | 208,259 | 174,230 | | | Gross Profit | 79,809 | 96,909 | 236,966 | 189,085 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 79,934 | 85,403 | 104,641 | 91,833 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 8,476 | 7,713 | 7,131 | 7,023 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (8,601) | 3,793 | 125,194 | 90,229 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,822) |
-
|
-
|
-
| | Earnings Before Interest And Taxes | (12,423) | 3,793 | 125,194 | 90,229 | | Interest Expense | 10,156 | 10,068 | 9,442 | 9,403 | | Income Before Tax | (22,579) | (6,275) | 115,752 | 80,826 | | Income Tax Expense | 302 | 1,160 | 886 | 138 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (22,881) | (7,435) | 114,866 | 80,688 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (22,881) | (7,435) | 114,866 | 80,688 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($22,881) | ($7,435) | $114,866 | $80,688 |
|
0.51% Nasdaq 
Income Statement
